Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Agreed Dudio. It’s not the first time I’ve seen a biotech company completely crash and burn with their terrible PR even though a lot of positivity should have been taken from the results. But yes, a palpable downbeat tone scared a lot of investors into selling today. It’s a hard to to stomach, especially for investors who have stuck with the company through thick and thin despite buying in at a high price. That said, from what I can see, Synairgen are fine tuning a product that will be targeted at specific patients who it could really help.. ie, those who, without it, could develop severe symptoms or even die. What’s more, everything points at it having excellent efficacy. We’ll just have to be patient until phase 3 trial results come through. Even if the product arrives on the market too late to have a profound effect on the pandemic (which I don’t think will be the case), it’s a matter of when, not if, another one hits us. Many hard lessons are being learnt from COVID-19 and governments all over the world will want to be ready. This will surely mean stockpiling proven, agnostic treatments like SNG001. That’s why I’m in for the long haul.
Punit, apologies if my previous post seemed patronising, having re-read it, it may have come across that way. You just seem highly strung and nervous when it comes to this stock and that’s not a good place to be.
Nope, I’m not a regular poster. I don’t consider myself qualified enough to comment on biotech stocks but lap up the insights I can find here and in other places. I am an experienced investor though and with this comes thick skin when faced with prices swinging back and forth. What keeps me calm is that I’ve done and continue doing my DD, it’s not difficult with the wealth of information some people post on here. I chose to invest, I then decided how much to invest based on my risk-reward analysis and how much I could afford to lose should things go pear shaped. I found that sweet spot and now I can sit back, stay in the loop and watch it play out without being too vulnerable to the emotion reactions we can all have when there are moments of high volatility. If you’re knowledgeable about a company, FUD and short term dips won’t affect you and you might even top up a little. I suspect you jumped in on momentum hoping to make a quick buck, which is fine, but if that’s your way of playing the game, I’d keep a close eye my blood pressure if I were you. Good luck!
Punit, you really shouldn’t be playing around with AIM stocks if you can’t handle volatility. We’re lucky to have some really helpful posters on this forum who do excellent research and are kind enough to share. If you’re not convinced that SNG has a bright future, you should sell up now and save yourself the stress you’re obviously suffering.
Tsla has made me a lot of money but more importantly, it’s made me a stronger investor when a stock I believe in is down. Might take longer than hoped to get back into green territory with sng but I’m confident it’ll happen in the next few months.